SECURITIES AND EXCHANGE COMMISSION

                             Washington, D. C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): August 5, 1998

                               ISONICS CORPORATION
             (Exact name of registrant as specified in its charter)

                                   California
                 (State or other jurisdiction of incorporation)

            001-12531                                77-0338561
     (Commission File No.)                (IRS Employer Identification No.)

                         4010 Moorpark Avenue, Suite 119
                           San Jose, California 95117
              (Address of principal executive offices and zip code)

       Registrant's telephone number, including area code: (408) 260-0155

                                        1






This Current Report on Form 8-K contains forward looking statements that involve
risks and uncertainties  relating to the acquisition by Isonics  Corporation,  a
California corporation ("Isonics"), of Chemotrade GmbH, a privately held company
("Chemotrade"),  including  the  risks:  inherent  in  acquiring  a  company  in
Chemotrade's  industry (e.g.  assumption of known and unknown liabilities); that
the synergies expected to result from the acquisition  described below might not
occur as  anticipated;  and that  management's  attention might be diverted from
day-to-day  business  activities.  Actual  results and  developments  may differ
materially  from those described in this Current  Report.  For more  information
about Isonics and risks relating to investing in Isonics, refer to Isonics' most
recent  reports  on Form  10-QSB and  Registration  Statement  on Form SB-2,  as
amended, Registration No. 333-13289.

Item 2.  Acquisition or Disposition of Assets.

On  July  21,  1998,   Isonics'   wholly  owned   German   subsidiary,   Des-Dur
Vermogensverwaltungs GmbH, acquired Chemotrade through the acquisition of all of
the  outstanding  capital  stock of  Chemotrade  from Mr.  Helmut  Swyen and Mr.
Herbert Hegener (the "Sellers").  The acquisition was accomplished pursuant to a
Sale and Purchase  Agreement dated as of May 29, 1998 and amended as of July 15,
1998 (the "Purchase Agreement").  In exchange for all of the outstanding capital
stock of  Chemotrade  on July 21, 1998,  Isonics paid  $758,700 in cash,  issued
357,730 shares of its Common Stock and issued two notes to the Sellers,  one for
$924,000  bearing  interest at 2% per month due September  15, 1998,  secured by
certain  accounts  receivable and a second note for $833,000 bearing interest at
10% per annum,  due June 1, 1999.  The shares of Isonics  Common Stock issued in
the acquisition were issued pursuant to Regulation S under the Securities Act of
1933,  as amended.  Payment of the second  note is  contingent  upon  Chemotrade
meeting minimum pretax earnings as defined in the Purchase  Agreement during the
sixteen  months  ending April 30, 1999 and twelve  months ending April 30, 2000.
The Sellers will receive additional consideration of $278,000 in cash if minimum
pretax  earnings as defined in the Purchase  Agreement are met during the twelve
months  ending  April 30,  2001.  The  purchase  price was  arrived  at  through
arms-length  negotiations.  The total  number of shares of Isonics  Common Stock
issued in connection with the acquisition are being held in escrow to secure the
obligations  of  Chemotrade  to  indemnify  Isonics  for  any  breaches  of  the
representations  and  warranties  of  Chemotrade  and to repay any  shortfall of
earnings  as  defined  for the  periods  ending  April 30,  1999 and  2000.  The
acquisition will be accounted for as a purchase.

In connection  with the purchase of  Chemotrade,  Isonics also acquired  seventy
five percent of the  outstanding  capital  stock of  Chemotrade  GmbH,  Leipzig.
Chemotrade is a supplier of stable and radioactive  isotopes.  Isonics currently
intends to maintain  Chemotrade as a wholly-owned  subsidiary and for Chemotrade
to continue to conduct its business as historically conducted.

A copy of the press release  announcing the signing of the Purchase Agreement is
attached hereto as Exhibit 99.1 and incorporated by reference  herein. A copy of
the press release  announcing the  consummation  of the  acquisition is attached
hereto as Exhibit 99.2 and incorporated by reference herein.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

             (a)   Financial Statements of Businesses Acquired.

              The  Registrant  believes that it would be  impractical to provide
              the required financial  statements at the time this Report on Form
              8-K is  filed.  The  Registrant  intends  to file  such  financial
              information as an amendment to this Form 8-K within 60 days of the
              date hereof.

              (b) Pro Forma Financial Information

              The  Registrant  believes that it would be  impractical to provide
              the  required  pro forma  financial  information  at the time this
              Report on Form 8-K is filed.  The Registrant  intends to file such
              financial  information  as an amendment to this Form 8-K within 60
              days of the date hereof.




             (c)   Exhibits.

  Exhibit No.         Description
  -----------         -----------

     2.1       Sale and Purchase  Agreement,  dated as of May 29, 1998,  between
               Isonics  Corporation,  a  California  corporation,   and  Herbert
               Hegener and Helmut Swyen. Disclosure Schedule has been omitted as
               permitted pursuant to the rules and regulations of the Securities
               and   Exchange   Commission   ("SEC"),   but  will  be  furnished
               supplementally to the SEC upon request).

     2.2       Purchase  Agreement,  dated as of July 15, 1998,  between Isonics
               Corporation,  a California  corporation,  and Herbert Hegener and
               Helmut Swyen.

     99.1      Press release announcing the execution of the Purchase Agreement.

     99.2      Press release announcing the consummation of the acquisition.


                                        2




                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                               ISONICS CORPORATION

     Dated: August 5, 1998                       By:   /s/ James Alexander
            --------------                       ---   -------------------

                                                           James Alexander
                                                           President and Chief
                                                           Executive Officer

                                        4





                                  EXHIBIT INDEX

 Exhibit No.       Description
 -----------       -----------

     2.1       Sale and Purchase  Agreement,  dated as of May 29, 1998,  between
               Isonics  Corporation,  a  California  corporation,   and  Herbert
               Hegener and Helmut Swyen. Disclosure Schedule has been omitted as
               permitted pursuant to the rules and regulations of the Securities
               and   Exchange   Commission   ("SEC"),   but  will  be  furnished
               supplementally to the SEC upon request).

     2.2       Purchase  Agreement,  dated as of July 15, 1998,  between Isonics
               Corporation,  a California  corporation,  and Herbert Hegener and
               Helmut Swyen.

     99.1      Press release announcing the execution of the Purchase Agreement.

     99.2      Press release announcing the consummation of the acquisition.